AI-Driven Consent Simplification Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of California, Los Angeles
- Study ID
- NCT07303517
- Status
- Recruiting
Conditions
- Communication
- Comprehension
- Disclosure
- Informed Consent
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Original ICF — BEHAVIORALParticipant will review the original ICF
- AI Simplified ICF — BEHAVIORALParticipant will review the AI Simplified ICF
- Podcast - Original ICF — BEHAVIORALListen to a podcast that is developed to provide an engaging format for the original ICF.
- Podcast - Simplified ICF — BEHAVIORALListen to a podcast that is developed to provide an engaging format for the simplified ICF.
Study Details
The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.
Key Dates
- Start date
- Jan 8, 2026
- Status verified
- May 2026
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 230 participants (estimated)
Arms
- Arm: Group 1-Adult participants - Arm AWill review the original ICF
- Arm: Group 1 - Adult participants - Arm BWill review the simplified ICF
- Arm: Group 1- Adult participants - Arm CWill listen to a podcast in conjunction to the original ICF
- Arm: Group 1-Adult participants - Arm DWill listen to a podcast in conjunction to the simplified ICF
- Arm: Group 2 - InvestigatorsPIs who are health providers that perform clinical trials
- Arm: Group 3 - IRB individualsIndividuals involved in IRB activities (chairs, committee members, staff)
Primary Outcome Measure
Quality of Informed Consent (QUIC) [ Time Frame: Day 1 (immediately after reviewing the ICF materials) ]
Central Contacts
- Erinn Knox(310) 490-4888
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA | Los Angeles | California | 90095 | - |
Find similar trials in Los Angeles, CA
Related Studies
- The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity NowRecruiting · Boston Children's Hospital · Birmingham, Alabama
- Supporting Just-In-Time Consent for Prenatal Screening: The INFORM StudyNot Yet Recruiting · Case Western Reserve University · San Francisco, California
- Families of Youth with Developmental Disabilities: a Theory-Based InterventionRecruiting · University of Notre Dame · Fort Wayne, Indiana
- Handoffs and Transitions in Critical Care - Understanding ScalabilityEnrolling By Invitation · University of Pennsylvania · Baltimore, Maryland